presented at ASH21: In the pivotal phase 2 ELARA trial, tisa-cel CARTcells produced a high rate of complete responses with a manageable safety profile in adults with r/r Follicular Lymphoma lymsm immunotherapy NovartisCancer ASH22
N.H.F. is an advisor or consultant for Roche/Genentech, TG Therapeutics, Verastem, Bayer, Celgene and Novartis and reports research support from Roche, Celgene, Gilead Sciences, TG Therapeutics, Novartis, AbbVie and BeiGene. M.
is an advisor or consultant for Novartis, Janssen, Roche, Jazz Pharmaceuticals, Amgen and Gilead Sciences; reports research support from Novartis, Janssen, Pfizer, Roche and Takeda; reports travel support from Roche, Gilead Sciences and Janssen; and reports patents, royalties or other intellectual property from Entourage Bioscience on cannabinoid derivatives. A.I.C.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelae - Nature MedicineTranscriptomic analyses of acute-phase whole blood from a large cohort of patients with COVID19 identify molecular determinants of post-infection long-term sequelae LongCOVID SARSCoV2 noambeckmann1 aw_charney DarwinAwdWinner
Read more »
Association of wearable device-measured vigorous intermittent lifestyle physical activity with mortality - Nature MedicineUsing data from wearable activity monitors, this study shows that short bursts of physical activity that are done as part of daily life activities and that are only 1 or 2 minutes in length are associated with lower mortality, similar to the effects of regular exercise.
Read more »
Effect of air pollution on the human immune system - Nature MedicineInhaled particulates from environmental pollutants accumulate in macrophages in lung-associated lymph nodes over years, compromising immune surveillance via direct effects on immune cell function and lymphoid architecture. These findings reveal the importance of improved air quality to preserve immune health against current and emerging pathogens.
Read more »
Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial - Nature MedicineIn patients with metastatic triple-negative BreastCancer, atezolizumab + anthracycline-based chemotherapy improves progression-free survival, including in PD-L1 negative disease SABCS22 andreashr GroupKyte AmundJon Oslounivsykehus UniOslo_MED BCsm
Read more »
UW Medicine: 2022 flu season off to 'historically severe' startHealth officials at UW Medicine say this year’s flu season is off to a “historically severe” start, and hospitalizations are their highest since 2011. FOX13
Read more »
More street medicine teams tackle the homeless health care crisisFrom CalMatters: People experiencing homelessness often have sporadic or no access to health care, resulting in costly, chronic conditions. A new statewide effort encourages Medi-Cal insurers to partner with street teams to improve care.
Read more »